HQL vs. HQH
HQL (Tekla Life Sciences Investors) and HQH (Tekla Healthcare Investors) are both stocks. Both operate in the Asset Management industry within the Financial Services sector. Over the past 10 years, HQL returned 10.15%/yr vs 8.25%/yr for HQH. Their 0.71 correlation means they have sometimes moved together and sometimes differently.
Performance
HQL vs. HQH - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with HQL having a 25.27% return and HQH slightly higher at 25.53%. Over the past 10 years, HQL has outperformed HQH with an annualized return of 10.15%, while HQH has yielded a comparatively lower 8.25% annualized return.
HQL
- 1D
- 2.23%
- 1M
- -2.09%
- 6M
- 22.43%
- YTD
- 25.27%
- 1Y
- 67.53%
- 3Y*
- 28.98%
- 5Y*
- 9.74%
- 10Y*
- 10.15%
- ALL TIME*
- 8.70%
HQH
- 1D
- 0.90%
- 1M
- 1.55%
- 6M
- 23.06%
- YTD
- 25.53%
- 1Y
- 59.08%
- 3Y*
- 23.84%
- 5Y*
- 7.36%
- 10Y*
- 8.25%
- ALL TIME*
- 10.65%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $5.31M | $5.82M | $4.25M | |
| $3.56M | $3.20M | $2.54M |
HQL vs. HQH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HQL Tekla Life Sciences Investors | 25.27% | 45.48% | 11.03% | 4.23% | -19.21% | 5.52% | 23.72% | 25.53% | -16.18% | 25.41% |
HQH Tekla Healthcare Investors | 25.53% | 34.12% | 10.22% | 1.22% | -17.27% | 7.99% | 24.82% | 26.80% | -13.08% | 15.97% |
Correlation
The correlation between HQL and HQH is 0.85, meaning they have usually moved in the same direction, including during past declines.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.85 |
Correlation (3Y) Balances recent behavior with more history. | 0.86 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.88 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.88 |
Correlation (All Time) Calculated using the full available price history since May 4, 1992 | 0.71 |
The correlation between HQL and HQH shifts across timeframes, from 0.71 (all time) to 0.88 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
HQL:
$599.04M
HQH:
$1.28B
HQL:
$6.27
HQH:
$6.05
HQL:
3.14
HQH:
3.69
HQL:
0.08
HQH:
0.25
HQL:
7.32
HQH:
37.70
HQL:
$79.82M
HQH:
$32.46M
HQL:
$56.06M
HQH:
$27.34M
HQL:
$150.93M
HQH:
$173.45M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HQL vs. HQH — Risk / Return Rank
HQL
HQH
HQL vs. HQH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tekla Life Sciences Investors (HQL) and Tekla Healthcare Investors (HQH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HQL | HQH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.21 | ||
| Sortino ratioReturn per unit of downside risk | +0.37 | ||
| Omega ratioGain probability vs. loss probability | 1.49 | 1.46 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 6.62 | 4.56 | +2.06 |
| Martin ratioReturn relative to average drawdown | 19.18 | 15.68 | +3.50 |
Loading charts...
Drawdowns
HQL vs. HQH - Drawdown Comparison
The maximum HQL drawdown since its inception was -62.65%, roughly equal to the maximum HQH drawdown of -62.36%. Use the drawdown chart below to compare losses from any high point for HQL and HQH.
Loading charts...
Drawdown Indicators
| HQL | HQH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.65% | -62.36% | -0.29% |
Max Drawdown (1Y)Largest decline over 1 year | -10.25% | -13.01% | +2.76% |
Max Drawdown (3Y)Largest decline over 3 years | -25.10% | -21.14% | -3.96% |
Max Drawdown (5Y)Largest decline over 5 years | -38.86% | -37.55% | -1.31% |
Max Drawdown (10Y)Largest decline over 10 years | -38.86% | -37.55% | -1.31% |
Current DrawdownCurrent decline from peak | -5.42% | 0.00% | -5.42% |
Average DrawdownAverage peak-to-trough decline | -22.17% | -20.97% | -1.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.53% | 3.78% | -0.25% |
Volatility
HQL vs. HQH - Volatility Comparison
Tekla Life Sciences Investors (HQL) has a higher volatility of 6.72% compared to Tekla Healthcare Investors (HQH) at 5.00%. This indicates that HQL's price experiences larger fluctuations and is considered to be riskier than HQH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HQL | HQH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.72% | 5.00% | +1.72% |
Volatility (6M)Calculated over the trailing 6-month period | 15.67% | 14.77% | +0.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.77% | 20.43% | +1.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.93% | 19.72% | +1.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.28% | 21.39% | +0.89% |
Dividends
HQL vs. HQH - Dividend Comparison
HQL's dividend yield for the trailing twelve months is around 10.36%, which matches HQH's 10.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HQH Tekla Healthcare Investors | 10.38% | 11.56% | 14.21% | 9.66% | 9.50% | 8.59% | 7.97% | 8.24% | 10.75% | 8.78% | 9.80% | 11.97% |
HQL Tekla Life Sciences Investors | 10.36% | 10.85% | 14.18% | 9.44% | 9.57% | 8.79% | 7.90% | 8.03% | 10.72% | 8.25% | 12.18% | 11.84% |
Financials
HQL vs. HQH - Financials Comparison
This section allows you to compare key financial metrics between Tekla Life Sciences Investors and Tekla Healthcare Investors. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
HQL and HQH have a correlation of 0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HQL has higher volatility (6.72%) compared to HQH (5.00%). In terms of maximum drawdown, HQL dropped -62.65% vs HQH's -62.36%.
HQL currently has the higher Sharpe Ratio (3.12 vs 2.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HQL and HQH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer